 |
Clinical Trial Design for Community-Acquired Pneumonia; Public Workshop
January 17-18, 2008
Silver Spring, Maryland
The Food and Drug Administration (FDA) is announcing a public workshop, cosponsored with the Infectious Diseases Society of America (IDSA), regarding scientific issues in clinical trial design for community-acquired pneumonia. This public workshop is intended to provide information for and gain perspective from health care providers, academia, and industry on various aspects of antimicrobial drug development for community-acquired pneumonia, including diagnosis of community-acquired pneumonia, effect of antimicrobial treatment for community-acquired pneumonia, endpoints for trials of community-acquired pneumonia, and statistical issues in analysis of results of trials in community-acquired pneumonia. The input from this public workshop will help in developing topics for further discussion.
The FR Notice, Agenda, and Transcripts from the workshop are available (see links below).
 Back
to Top 
Back to Meetings
 PDF requires the free Adobe Acrobat Reader
Date created: December 21, 2007, updated March 19, 2008 |
|
